Skip to content

Muscarinic receptor genotype

Muscarinic receptor genotype - Muscarinic receptor genotype

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30915
Enrollment
200
Registered
2007-07-18
Start date
2007-06-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hypertrophia overactive bladder

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Male patients treated in the department of Urology of the Amsterdam Medical Center (AMC) of any age. Any patient that receives any kind of treatment in which prostate tissue is harvested and and not required for pathological analysis.

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: Genotype for the polymorphism in the M2 receptor gene promoter will be related to abundance of M2 receptor mRNA in prostatic tissue; mRNA for housekeeping genes and for other muscarinic receptor subtypes will be internal controls

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)